Skip to main content

ADVERTISEMENT

Alan W. Heldman, MD

06/19/2008
Dr. Heldman was the first to demonstrate effective reduction of coronary restenosis in an animal model with a prototype drug eluting stent. His clinical interests include the treatment and prevention of coronary restenosis; complex coronary...
Dr. Heldman was the first to demonstrate effective reduction of coronary restenosis in an animal model with a prototype drug eluting stent. His clinical interests include the treatment and prevention of coronary restenosis; complex coronary...
Dr. Heldman was the first to...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Dr. Heldman was the first to demonstrate effective reduction of coronary restenosis in an animal model with a prototype drug eluting stent. His clinical interests include the treatment and prevention of coronary restenosis; complex coronary...
Dr. Heldman was the first to demonstrate effective reduction of coronary restenosis in an animal model with a prototype drug eluting stent. His clinical interests include the treatment and prevention of coronary restenosis; complex coronary...
Dr. Heldman was the first to...
06/19/2008
Cath Lab Digest
Case Report
08/01/2008
ABSTRACT: We report the treatment of an acute myocardial infarction presenting late with thrombotic total occlusion of a saphenous vein graft. A novel approach was used to prevent microvascular obstruction and reperfusion injury, with a...
ABSTRACT: We report the treatment of an acute myocardial infarction presenting late with thrombotic total occlusion of a saphenous vein graft. A novel approach was used to prevent microvascular obstruction and reperfusion injury, with a...
ABSTRACT: We report the...
08/01/2008
Journal of Invasive Cardiology